Phase 1 study of a recombinant mutant protective antigen of Bacillus anthracis.
Bellanti JA, Lin FY, Chu C, Shiloach J, Leppla SH, Benavides GA, Karpas A, Moayeri M, Guo C, Robbins JB, Schneerson R.
Bellanti JA, et al. Among authors: lin fy.
Clin Vaccine Immunol. 2012 Feb;19(2):140-5. doi: 10.1128/CVI.05556-11. Epub 2011 Dec 21.
Clin Vaccine Immunol. 2012.
PMID: 22190398
Free PMC article.
Clinical Trial.